All stock lists
Paramount Gold Nevada Corp. (New York Stock Exchange Arca:PZG)
US · Delayed Price · Currency is USD
Basic Materials · Gold
$0.94-$0.01 (-0.84%)
Market cap
$80.8M
Insider Score
Health Score
Analyst consensus
Listed since
Apr 10, 2015
Website
Insider Score
––Not scored
PZG Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From PZG’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars
Profitability—
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$6.7M
- Net margin
- —
Leverage20 / 20
Little or no net debt.
- Total debt
- $0
- Cash
- $8.3M
- Debt / equity
- 0.00
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $9.5M
- Current liabilities
- $3.9M
- Current ratio
- 2.48
Cash generation3 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$7.0M
- Free cash flow
- -$7.1M
Dilution & runway9 / 20
Some dilution over the past year.
- Shares outstanding
- 86.2M
- Share growth (1y)
- 13.0%
- Cash runway
- 14 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
PZG Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | $244.70 K | $117.07 K | $106.67 K | $213.31 K | $188.61 K | $204.76 K |
| Gross Profit | -$244.70 K | -$117.07 K | -$106.67 K | -$213.31 K | -$188.61 K | -$204.76 K |
| SG&A Expense | $553.35 K | -$374.50 K | $554.89 K | $1.11 M | $675.03 K | $671.88 K |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $553.35 K | $2.19 M | $2.25 M | $1.93 M | $1.34 M | $1.93 M |
| Operating Income | -$798.05 K | -$2.30 M | -$2.36 M | -$2.15 M | -$1.52 M | -$2.14 M |
| Pretax Income | $4.56 M | -$1.90 M | -$4.90 M | -$4.43 M | -$4.32 M | -$2.81 M |
| Tax Provision | $0.00 | $4.85 K | $0.00 | $0.00 | $0.00 | $19.25 K |
| Net Income | $4.56 M | -$1.91 M | -$4.90 M | -$4.43 M | -$4.32 M | -$2.83 M |
| EPS (Basic) | $0.05 | -$0.02 | -$0.06 | -$0.06 | -$0.06 | -$0.04 |
| EPS (Diluted) | $0.05 | -$0.02 | -$0.06 | -$0.06 | -$0.06 | -$0.04 |
| Shares Outstanding | 86.16 M | 86.12 M | 83.13 M | 78.44 M | 76.27 M | 71.00 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.